We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boston Scientific said that the FDA approved new directions for its Taxus Express2
drug-coated coronary stent, allowing doctors to perform magnetic resonance imaging
(MRI) on a patient soon after receiving the device.
Gen-Probe announced that it has received a tentative award in its arbitration
with Bayer HealthCare concerning the parties' collaboration for the development
and sale of nucleic acid diagnostic tests for viral organisms.
Fisher Scientific International completed its sale of Atos Medical AB, a manufacturer
of ear, nose and throat medical devices with 2004 sales totaling $35 million,
to Nordic Capital for $110 million in cash.
ThermoGenesis announced that the company and Biomet reached agreement for the
company to supply Biomet's subsidiary, Cell Factor Technologies, with disposable
kits that produce stable, activated thrombin from the patients own blood in
less than 30 minutes.
Sweden's Elekta AB said it completed the $250 million acquisition of Mountain
View, Calif.-based IMPAC Medical Systems, following approval of the transaction
by IMPAC's stockholders.
Covalon Technologies announced that it has responded to the FDA's request for
further information regarding the company's 510(k) premarket notification for
its ColActive wound dressing.
International Isotopes announced completion of a four-year Cobalt Source Recycle
Agreement with Alpha-Omega Services (AOS) of Bellflower, Calif. AOS designs
and develops radioactive sources and accessories for the brachytherapy market.
Xilas Medical said that the National Institutes of
Health (NIH) awarded the local company an $880,000 grant to conduct Phase II
clinical trials on its TempTouch RM infrared temperature remote-monitoring device.
CardioTech International announced that CorNova has successfully completed its
Series A financing of $3 million, enabling CorNova to continue executing its
business plan.